Eyelid inflammation affects millions of Americans every year.
Over 85% of eyelid inflammation patients, also suffer from inflammatory ocular conditions, such as Meibomian Gland Dysfunction (MGD), blepharities and eyelid telangiectasia.
Lumenis invites you to think outside the eye and offer your patients a solution to their eye related problems with M22™.
M22™ combines Intense Pulsed Light (IPL) and unique Optimal Pulse Technology (OPT™) to treat dry & itchy eyes.
Meibomian Gland Dysfunction is one of the leading causes of Dry Eye disease (DED), affecting millions worldwide.
DED symptoms pose substantial quality of life issues for MGD patients. In recent years,Optimal Pulse technology (OPT) has emerged as an effective alternative for patients with MGD, who have not achieved adequate results using other means.
OPT is an excellent technology for treating vascular skin lesions. OPT is selectively absorbed in the hemoglobin of abnormal blood vessels, and destroys them by thrombosis.
When using OPT on your patient’s facial skin, especially in OPT™ is the most advanced IPL technology, developed by Lumenis, and is unique to Lumenis M22™.
M22 OPT™ offers unique features for enhanced physician and patient comfort:
With M22 your office gets a powerful multi-platform capability in a small, staff friendly package. Your patients get treatment outcomes that build loyalty and boost referrals.
VIETCAN SERVICE & TRADING J.S.C
Address: Room 4A, JVPE Building, Quang Trung Software Park, Tan Chanh Hiep Ward, District 12, Ho Chi Minh City, Vietnam
License No. 0302438819, 11th additional issuance on March 27, 2018.
Place of issue: Department of Planning and Investment HCMC.
Phone: +84 28 6290 8200 – Email: [email protected]
Copyright by VietCan 2019
